NanoVibronix has announced an intelligent robot to automate and manage bedside feeding. The new platform tackles the need to manage increasing numbers of patients with complex health needs while clinical staff numbers continue to fall.

ENvue Drive is being developed to automate electromagnetic navigation for enteral and vascular access procedures at the bedside.

Each year, tens of millions of nasoenteric tube and vascular access procedures are performed globally. ENvue’s new robotic platform is positioned to address a growing clinical need to automate high-volume, bedside procedures in the face of workforce shortages and increasing patient complexity.

The system, now in engineering development, is being designed to integrate with the Company’s FDA-cleared electromagnetic guidance technology for enteral access, offering automated alignment and positional stability, while allowing clinicians to remain in full control.

The robotic platform is currently in preclinical development phase, with engineering prototypes in process and clinical advisor input underway. The system has not yet been submitted to the U.S. Food and Drug Administration (FDA) and is not yet cleared for clinical use.

The Company expects to initiate formal regulatory planning and submission milestones later this year and anticipates having a functional prototype by year-end. All future development remains subject to applicable regulatory approvals.

“ENvue’s Drive platform marks a transformative move for bedside clinical care,” said Dr. Doron Besser, CEO of NanoVibronix and ENvue Medical. “By embedding intelligent robotics into high frequency clinical workflows, starting with feeding tubes and expanding into vascular areas, we believe that we are addressing a major clinical challenge of doing more with fewer hands without compromising precision or safety while giving clinicians a new level of confidence and consistency in care.

“Importantly, the Drive platform is a scalable foundation for intelligent bedside navigation. Through this initiative, we believe we are building a future-ready solution portfolio that can evolve with clinical demands across multiple care settings and drive growth.”